Menu
Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 13 » default
Clinical Pharmacology: Advances and Applications
ISSN: 1179-1438
- View all (258)
- Volume 15, 2023 (3)
- Volume 14, 2022 (12)
- Volume 13, 2021 (27)
- Volume 12, 2020 (28)
- Volume 11, 2019 (16)
- Volume 10, 2018 (19)
- Volume 9, 2017 (19)
- Volume 8, 2016 (20)
- Volume 7, 2015 (14)
- Volume 6, 2014 (23)
- Volume 5, 2013 (30)
- Volume 4, 2012 (11)
- Volume 3, 2011 (7)
- Volume 2, 2010 (28)
- Volume 1, 2009 (1)
Archive: Volume 13, 2021
Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience
Roshmi RR, Yokota T
Clinical Pharmacology: Advances and Applications 2021, 13:235-242
Published Date: 16 December 2021
Potential of Quinine Sulfate for COVID-19 Treatment and Its Safety Profile: Review
Latarissa IR, Barliana MI, Meiliana A, Lestari K
Clinical Pharmacology: Advances and Applications 2021, 13:225-234
Published Date: 6 December 2021
Pharmacological Management of Urinary Incontinence: Current and Emerging Treatment
Gandi C, Sacco E
Clinical Pharmacology: Advances and Applications 2021, 13:209-223
Published Date: 25 November 2021
A Case of Thrombocytosis Associated with Enoxaparin Therapy in an Adolescent
Murray R, Tobias JT
Clinical Pharmacology: Advances and Applications 2021, 13:203-207
Published Date: 18 October 2021
Comparing the Efficacy of a Nurse-Driven and a Physician-Driven Diabetic Ketoacidosis (DKA) Treatment Protocol
Anis TR, Boudreau M, Thornton T
Clinical Pharmacology: Advances and Applications 2021, 13:197-202
Published Date: 7 October 2021
Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19
Panda PK, Singh BO, Moirangthem B, Bahurupi YA, Saha S, Saini G, Dhar M, Bairwa M, Pai VS, Agarwal A, Sindhwani G, Handu S, Kant R
Clinical Pharmacology: Advances and Applications 2021, 13:185-195
Published Date: 29 September 2021
Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban
Anis TR, Jandreau W
Clinical Pharmacology: Advances and Applications 2021, 13:181-184
Published Date: 29 September 2021
Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor
Joseph NS, Tai YT, Anderson KC, Lonial S
Clinical Pharmacology: Advances and Applications 2021, 13:169-180
Published Date: 18 August 2021
Evaluation of Antimalarial Activity of 80% Methanolic Root Extract of Dorstenia barnimiana Against Plasmodium berghei–Infected Mice
Derebe D, Wubetu M, Alamirew A
Clinical Pharmacology: Advances and Applications 2021, 13:157-167
Published Date: 16 July 2021
Evaluation of the Pharmacokinetics of Trazpiroben (TAK-906), a Peripherally Selective D2/D3 Dopamine Receptor Antagonist, in the Presence and Absence of Itraconazole, a Potent CYP 3A4 Inhibitor
Chen C, Zhang W, Bari M, Almansa C, Baratta M, Rosario M
Clinical Pharmacology: Advances and Applications 2021, 13:145-155
Published Date: 12 July 2021
Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective
Yamamoto T
Clinical Pharmacology: Advances and Applications 2021, 13:135-143
Published Date: 23 June 2021
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study
Gordon D, Hellriegel ET, Hope HR, Burt D, Monahan JB
Clinical Pharmacology: Advances and Applications 2021, 13:123-134
Published Date: 10 June 2021
Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis: A Population Pharmacokinetic Study
Santamaria E, Izquierdo I, Valle M
Clinical Pharmacology: Advances and Applications 2021, 13:115-122
Published Date: 8 June 2021
Determination of Caffeine and Hydrogen Peroxide Antioxidant Activity of Raw and Roasted Coffee Beans Around Habru Woreda, Ethiopia Using UV-Vis Spectroscopy
Legas Muhammed B, Hussen Seid M, Habte AT
Clinical Pharmacology: Advances and Applications 2021, 13:101-113
Published Date: 24 May 2021
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain
Thanawala S, Shah R, Somepalli V, Alluri KV, Desomayanandam P, Bhuvanendran A
Clinical Pharmacology: Advances and Applications 2021, 13:91-100
Published Date: 21 May 2021
Metformin as a Potential Adjuvant Antimicrobial Agent Against Multidrug Resistant Bacteria
Masadeh MM, Alzoubi KH, Masadeh MM, Aburashed ZO
Clinical Pharmacology: Advances and Applications 2021, 13:83-90
Published Date: 11 May 2021
An Investigator-Initiated, Prospective, Single-Center, Open-Label Clinical Study to Evaluate Safety and Performance of Intra-Articular Hyaluronic Acid (IA-HA) (Biovisc Ortho) in Patients with Osteoarthritis (OA) of the Knee
Gupta A, Channaveera C, Anand V, Sethi S
Clinical Pharmacology: Advances and Applications 2021, 13:73-82
Published Date: 11 May 2021
Population Pharmacokinetics of CC-122
Cheng Y, Chen J, Pourdehnad M, Zhou S, Li Y
Clinical Pharmacology: Advances and Applications 2021, 13:61-71
Published Date: 28 April 2021
Clinical Impact of Liraglutide as a Treatment of Obesity
Alruwaili H, Dehestani B, le Roux CW
Clinical Pharmacology: Advances and Applications 2021, 13:53-60
Published Date: 11 March 2021
Efficacy of Generic Atorvastatin in a Real-World Setting
Manasirisuk P, Chainirun N, Tiamkao S, Lertsinudom S, Phunikhom K, Sawunyavisuth B, Sawanyawisuth K
Clinical Pharmacology: Advances and Applications 2021, 13:45-51
Published Date: 5 March 2021
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2021, 13:43-44
Published Date: 3 March 2021
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Retraction]
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2021, 13:41-42
Published Date: 3 March 2021
Administration of Supplemental L-Tyrosine with Phenelzine: a Clinical Literature Review [Retraction]
Hinz M, Stein A, Cole T, Ryan P
Clinical Pharmacology: Advances and Applications 2021, 13:39-40
Published Date: 3 March 2021
Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion
Rouland A, Bouillet B, Legris P, Simoneau I, Petit JM, Vergès B
Clinical Pharmacology: Advances and Applications 2021, 13:33-37
Published Date: 5 February 2021
Pharmacokinetics and Toxicities of Oral Docetaxel Formulations Co-Administered with Ritonavir in Phase I Trials
Vermunt M, Marchetti S, Beijnen J
Clinical Pharmacology: Advances and Applications 2021, 13:21-32
Published Date: 27 January 2021
Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method
Turner R, Wevrett SR, Edmunds S, Brown MB, Kulasekaran A, Adegoke O, Farrah J
Clinical Pharmacology: Advances and Applications 2021, 13:13-20
Published Date: 19 January 2021
The Impact of First-Line Anti-Tubercular Drugs’ Pharmacokinetics on Treatment Outcome: A Systematic Review
Sileshi T, Tadesse E, Makonnen E, Aklillu E
Clinical Pharmacology: Advances and Applications 2021, 13:1-12
Published Date: 12 January 2021